Waning of vaccine-induced immunity: Is it a problem in Africa?

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 304-305

  Aaby, Peter ^a,b   Gisse, Badara ^b   Simondon, François ^c   Samb, Badara ^d   Soumaré, Masserigne ^e,f  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b DEPARTMENT OF EPIDEMIOLOGY RESEARCH   (Denmark)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d INSERM   (France)

^e Centre Hospitalier Universitaire Dakar   (Senegal)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VACCINE; VIRUS ANTIBODY;

ADOLESCENT; AFRICA; AGE; BIOLOGY; BLOOD; CHILD; CRITIQUE; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRY; DISEASE TRANSMISSION; DISEASES; EPIDEMIC; FEMALE; HEALTH; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; INFANT; JUVENILE; MALE; MEASLES; MEASLES VIRUS; MEASLES--PREVENTION AND CONTROL; NOTE; PHYSIOLOGY; POPULATION; POPULATION AND POPULATION RELATED PHENOMENA; PRESCHOOL CHILD; PRIMARY HEALTH CARE; SCHOOL; SENEGAL; TREATMENT FAILURE; VIRAL DISEASES;

AFRICA; AGE FACTORS; BIOLOGY; CHILD; CRITIQUE; DELIVERY OF HEALTH CARE; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; HEALTH; HEALTH SERVICES; IMMUNITY; IMMUNIZATION; MEASLES--PREVENTION AND CONTROL; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; PRIMARY HEALTH CARE; VACCINES; VIRAL DISEASES; YOUTH;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; SCHOOLS; SENEGAL; TREATMENT FAILURE;

EID: 0033556840     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009813     Document Type: Article

References (6)

1. Strebel P, Guris D, Papania M, et al. Invited commentary: vaccine failure or failure to vaccinate? Am J Epidemiol 1999:149:302-3.
2. Cisse B, Aaby P, Simondon F, et al. Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. Am J Epidemiol 1999;149:295-301.
3. Whittle HC, Aaby P, Samb B, et al. Serological responses 5-7 years after immunization with high and standard titre measles vaccines. Pediatr Infect Dis J (in press).
4. Whittle H, Aaby P, Samb B, et al. The importance of subclinical measles in maintaining immunity in vaccinated children in West Africa. Lancet (in press).
5. Samb B, Aaby P, Whittle H, et al. Protective efficacy of highlitre measles vaccines administered from the age of five months: a community study in rural Senegal. Trans R Soc Trop Med Hyg 1993;87:697-701.
6. Garly ML, Martins CL, Baie C, et al. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy. Int J Epidemiol (in press).